Formation of DNA-damaging nitroso compounds by interaction of drugs with nitrite. A preliminary screening for detecting potentially hazardous drugs.

Fifty-seven theoretically nitrosatable widely used drugs that are commonly administered orally have been screened to determine the formation of nitroso compounds by drug-nitrite interaction and to evaluate the genotoxicity of their nitrosation products against Chinese hamster ovary (CHO) cells, measured as DNA-damaging potency by the alkaline elution technique. The drug (0.1 mmol) was reacted with NaNO2 (0.4 mmol) at pH 3-3.5 for 1 h. Nitroso compounds were present in varying yield in the nitrosation mixture of 47 drugs. Twenty-two drugs formed direct-acting nitroso compounds capable of producing DNA fragmentation, i.e., a statistically significant (p less than 0.01) increase in the elution rate of CHO cell DNA. On a molar basis, their DNA-damaging potency varied over a 570-fold range, with 12 exhibiting greater potency than that of N-nitroso-N-methylurea.

[1]  H. Shimizu,et al.  Mutagenic activity of N-nitrosomethamphetamine and N-nitrosoephedrine. , 1983, Cancer letters.

[2]  M. O. Bradley,et al.  Evaluation of the alkaline elution/rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential. , 1983, Mutation research.

[3]  G. Brambilla,et al.  DNA damage induced by nitrosated ranitidine in cultured mammalian cells. , 1983, Toxicology letters.

[4]  J. Chen,et al.  Drug interactions. III. Formation of nitrosamines from therapeutic drugs. Formation, mutagenic properties and safety assessment of propranolol hydrochloride with respect to the intragastric formation of N-nitrosopropranolol under conditions found in patients. , 1983, The Journal of pharmacology and experimental therapeutics.

[5]  J. Chen,et al.  Drug interactions. II. Formation of nitrosamines from therapeutic drugs. Properties and kinetics of the formation of N-nitrosopropranolol from nitrite and the secondary amine propranolol hydrochloride. , 1983, The Journal of pharmacology and experimental therapeutics.

[6]  S. De Flora,et al.  Genotoxicity of nitrosated ranitidine. , 1983, Carcinogenesis.

[7]  B. Henderson,et al.  N-Nitroso compounds and childhood brain tumors: a case-control study. , 1982, Cancer research.

[8]  Y. Takeda,et al.  Formation of nitroso compounds and mutagens from cinnarizine, ethambutol, piromidic acid, pyridinol carbamate and tiaramide by drug/nitrite interaction. , 1982, Cancer letters.

[9]  T. Mitsuoka,et al.  Increase in faecal nitrosamines in Japanese individuals given a Western diet , 1981, Nature.

[10]  L. E. Martin,et al.  SAFETY OF RANITIDINE , 1981, The Lancet.

[11]  H. Bartsch,et al.  Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excreted in the urine. , 1981, Cancer research.

[12]  Y. Takeda,et al.  Formation of nitroso compounds and mutagens from tranquilizers by drug/nitrite interaction. , 1981, Cancer letters.

[13]  G. Brambilla,et al.  Quantitative correlation among DNA damaging potency of six N-nitroso compounds and their potency in inducing tumor growth and bacterial mutations , 1981 .

[14]  J. Fornwald,et al.  Nitrosation and mutagenicity of some amine drugs. , 1980, Toxicology and applied pharmacology.

[15]  R. Preussmann.  Dose-response studies and 'no-effect-levels' of N-nitroso compounds: some general aspects. , 1980, Oncology.

[16]  B. Singer.  N-nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis. , 1979, Journal of the National Cancer Institute.

[17]  G. Eisenbrand,et al.  Carcinogenicity of N-nitrosoephedrine in rats. , 1978, Cancer letters.

[18]  J. Swenberg,et al.  Detection of DNA damage induced in vivo following exposure of rats to carcinogens. , 1978, Cancer research.

[19]  S. Mirvish,et al.  N-Nitroso derivatives of hydrochlorothiazide, niridazole, and tolbutamide. , 1977, Toxicology and applied pharmacology.

[20]  K. Kohn,et al.  Fractionation of DNA from mammalian cells by alkaline elution. , 1976, Biochemistry.

[21]  P. Harbach,et al.  In vitro DNA damage/alkaline elution assay for predicting carcinogenic potential. , 1976, Biochemical and biophysical research communications.

[22]  G. Krishna,et al.  Drug-nitrite interactions: formation of N-nitroso, C-nitroso, and nitro compounds from sodium nitrite and various drugs under physiological conditions. , 1975, Journal of pharmaceutical sciences.

[23]  M. C. Archer,et al.  Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine. , 1975, Cancer research.

[24]  S. Tannenbaum,et al.  A MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1975, The Lancet.

[25]  S. Mirvish.  Formation of N-nitroso compounds: chemistry, kinetics, and in vivo occurrence. , 1975, Toxicology and applied pharmacology.

[26]  M. C. Archer,et al.  Quinazolines and 1,4‐benzodiazepines. LXV some transformations of chlordiazepoxide , 1974 .

[27]  H. Bartsch,et al.  Nitrosation of d-N,N'-bis(1-hydroxymethylpropyl)ethylenediamine, an antitubercular drug. , 1974, Journal of the National Cancer Institute.

[28]  W Lijinsky,et al.  Reaction of drugs with nitrous acid as a source of carcinogenic nitrosamines. , 1974, Cancer research.

[29]  G. Hawksworth,et al.  Bacteria, Nitrosamines and Cancer of the Stomach , 1973, British Journal of Cancer.

[30]  W. Lijinsky,et al.  Carcinogenic Nitrosamines formed by Drug/Nitrite Interactions , 1972, Nature.

[31]  L. Rümke,et al.  CHAPTER 3 – Design, Statistical Analysis and Interpretation , 1964 .